Effect of Tablet Sildenafil in Intrauterine growth restrictio
Phase 4
- Conditions
- Health Condition 1: O352- Maternal care for (suspected) hereditary disease in fetusHealth Condition 2: O098- Supervision of other high risk pregnancies
- Registration Number
- CTRI/2024/03/064340
- Lead Sponsor
- Tayba Nehal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. From 28-37 weeks POG.
2. singleton pregnancy.
3. normal fetal Doppler study.
4. uncomplicated intra uterine growth restriction
Exclusion Criteria
1. fetal malformation
2. severe preeclampsia
3. maternal coexisting complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-Symphysio fundal height match period of gestation +/- 2 weeks. 2-AFI more than 5 <br/ ><br>3-fetal weight above10th percentile for gestational ageTimepoint: from 28 -37 weeks POG <br/ ><br>for one year
- Secondary Outcome Measures
Name Time Method duration of hospital stayTimepoint: at discharge